Kayog, Tayanor K.
HRN: 22-49-26 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/19/2023
METRONIDAZOLE 500MG (TAB)
01/19/2023
01/26/2023
PO
500
Tid
Ltcs
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes